182 related articles for article (PubMed ID: 33592037)
1. The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment.
Usher-Smith JA; Mills KM; Riedinger C; Saunders CL; Helsingen LM; Lytvyn L; Buskermolen M; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G; Griffin SJ
PLoS One; 2021; 16(2):e0246991. PubMed ID: 33592037
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
[TBL] [Abstract][Full Text] [Related]
3. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
4. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study.
Buskermolen M; Cenin DR; Helsingen LM; Guyatt G; Vandvik PO; Haug U; Bretthauer M; Lansdorp-Vogelaar I
BMJ; 2019 Oct; 367():l5383. PubMed ID: 31578177
[TBL] [Abstract][Full Text] [Related]
6. Screening for colorectal cancer using the faecal occult blood test, Hemoccult.
Hewitson P; Glasziou P; Irwig L; Towler B; Watson E
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD001216. PubMed ID: 17253456
[TBL] [Abstract][Full Text] [Related]
7. The impact of personalised risk information compared to a positive/negative result on informed choice and intention to undergo colonoscopy following colorectal Cancer screening in Scotland (PERICCS) - a randomised controlled trial: study protocol.
Steele RJC; Digby J; Chambers JA; O'Carroll RE
BMC Public Health; 2019 Apr; 19(1):411. PubMed ID: 30991987
[TBL] [Abstract][Full Text] [Related]
8. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
[TBL] [Abstract][Full Text] [Related]
9. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
[TBL] [Abstract][Full Text] [Related]
10. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
11. Effects of numerical information on intention to participate in cervical screening among women offered HPV vaccination: a randomised study.
Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
Scand J Prim Health Care; 2016 Dec; 34(4):401-419. PubMed ID: 27845597
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR.
Hoffmann S; Crispin A; Lindoerfer D; Sroczynski G; Siebert U; Mansmann U; Consortium F
BMC Gastroenterol; 2020 May; 20(1):131. PubMed ID: 32370777
[TBL] [Abstract][Full Text] [Related]
14. Perceived Importance of the Benefits and Harms of Colorectal Cancer Screening: A Best-Worst Scaling Study.
Pluymen LPM; Yebyo HG; Stegeman I; Fransen MP; Dekker E; Brabers AEM; Leeflang MMG
Value Health; 2023 Jun; 26(6):918-924. PubMed ID: 36646279
[TBL] [Abstract][Full Text] [Related]
15. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Lin JS; Perdue LA; Henrikson NB; Bean SI; Blasi PR
JAMA; 2021 May; 325(19):1978-1998. PubMed ID: 34003220
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
[TBL] [Abstract][Full Text] [Related]
17. Survey mode and asking about future intentions did not impact self-reported colorectal cancer screening accuracy.
Beebe TJ; Ziegenfuss JY; Jenkins SM; Lackore KA; Johnson TP
BMC Med Res Methodol; 2014 Feb; 14():19. PubMed ID: 24499399
[TBL] [Abstract][Full Text] [Related]
18. Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy.
Bonello B; Ghanouni A; Bowyer HL; MacRae E; Atkin W; Halloran SP; Wardle J; von Wagner C
BMC Gastroenterol; 2016 Sep; 16(1):113. PubMed ID: 27618798
[TBL] [Abstract][Full Text] [Related]
19. The impact of descriptive norms on motivation to participate in cancer screening - Evidence from online experiments.
von Wagner C; Hirst Y; Waller J; Ghanouni A; McGregor LM; Kerrison RS; Verstraete W; Vlaev I; Sieverding M; Stoffel ST
Patient Educ Couns; 2019 Sep; 102(9):1621-1628. PubMed ID: 30975450
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
